Advertisement
Screener

VHCP Management, LLC Historic Quarter Change: USA Stocks, New

VHCP Management, LLC historic quarter change: USA Stocks, New

In share positions in stocks (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, VHCP Management, LLC opened 7 positions, added to 3, reduced 13 and sold out of 5.

  • Q1 2016: Stock BCRX; Country of operation United States; Class COM; Shares before 0.
  • Q1 2016: Stock ONC; Country of operation —; Class COM; Shares before 0.
  • Q4 2015: Stock CTMX; Country of operation United States; Class COM; Shares before 0.
  • Q3 2015: Stock RGNX; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1479355), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-13); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-13); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2016BCRX
BioCryst Pharmaceuticals Inc
United StatesCOM0562,943+562,943$0$1,593,000+$1,593,0002016-05-13
Q1 2016ONC
BeiGene Ltd
COM051,000+51,000$0$1,495,000+$1,495,0002016-05-13
Q4 2015CTMX
CytomX Therapeutics Inc
United StatesCOM075,000+75,000$0$1,565,000+$1,565,0002016-02-12
Q3 2015RGNX
REGENXBIO Inc
United StatesCOM01,083,454+1,083,454$0$20,178,000+$20,178,0002015-11-13
Q4 2014CHRS
Coherus Biosciences Inc
United StatesCOM0870,269+870,269$0$13,070,000+$13,070,0002015-02-13
Q1 2014HRTX
Heron Therapeutics Inc
United StatesCOM01,095,734+1,095,734$0$15,242,000+$15,242,0002014-05-14
Q1 2014XNCR
Xencor Inc
United StatesCOM088,400+88,400$0$1,037,000+$1,037,0002014-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet